查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1991594

全球体外膜氧合（ECMO）设备市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Extracorporeal Membrane Oxygenation Machine Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 161 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计体外膜氧合（ECMO）设备的市场规模将从 2025 年的 3.8302 亿美元增长到 2034 年的 6.5374 亿美元，并预计从 2026 年到 2034 年将以 6.12% 的复合年增长率增长。

由于重症监护领域对先进生命维持系统的需求不断增长，体外膜氧合（ECMO）设备的全球市场正稳步成长。 ECMO设备透过在体外为血液供氧，为严重心臟衰竭衰竭患者提供临时生命支持。这些设备通常用于加护病房以及复杂的心臟和呼吸治疗。

该市场的主要驱动因素是严重呼吸系统和心血管疾病发生率的不断上升。体外膜氧合（ECMO）在急性呼吸窘迫症候群（ARDS）等严重的应用日益广泛，显着扩大了其在医院的部署。此外，医疗技术的进步和病患监测系统的改进也提高了ECMO治疗的安全性和有效性。

随着医疗系统加大对先进紧急医疗技术的投资，体外膜氧合（ECMO）设备市场预计将持续成长。生命维持设备的持续研发将提升设备性能并改善患者预后。此外，医疗基础设施的扩建和医护人员培训的加强也有望推动市场成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球体外膜氧合（ECMO）设备市场：依组件划分

  • 市场分析、洞察与预测
  • 泵浦
  • 氧合器
  • 控制器
  • 套管
  • 配件

第五章 全球体外膜氧合（ECMO）设备市场：依治疗方法划分

  • 市场分析、洞察与预测
  • 静脉 - 动脉
  • 静脉-静脉
  • 动脉-静脉

第六章 全球体外膜氧合（ECMO）设备市场：依应用划分

  • 市场分析、洞察与预测
  • 呼吸系统
  • 为了心
  • ECPR

第七章 全球体外膜氧合（ECMO）设备市场：依病患类型划分

  • 市场分析、洞察与预测
  • 新生
  • 儿童
  • 成人

第八章 全球体外膜氧合（ECMO）设备市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第九章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第十章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Medtronic Plc
    • Maquet Holding
    • Microport Scientific Corporation
    • Terumo Cardiovascular System Corporation
    • Medos Medizintechnik
    • Nipro Medical Corporation
    • LivaNova PLC
    • CytoSorbents Corporation
    • Eurosets SRL
简介目录
Product Code: VMR11216884

The Extracorporeal Membrane Oxygenation Machine Market size is expected to reach USD 653.74 Million in 2034 from USD 383.02 Million (2025) growing at a CAGR of 6.12% during 2026-2034.

The global extracorporeal membrane oxygenation (ECMO) machine market is growing steadily due to the increasing demand for advanced life-support systems in critical care settings. ECMO machines provide temporary support for patients with severe heart or lung failure by oxygenating the blood outside the body. These devices are commonly used in intensive care units and during complex cardiac or respiratory treatments.

A key driver of this market is the rising incidence of severe respiratory and cardiovascular diseases. The increased use of ECMO during critical conditions such as acute respiratory distress syndrome has significantly expanded its adoption in hospitals. Additionally, advancements in medical technology and improved patient monitoring systems are enhancing the safety and effectiveness of ECMO treatments.

Looking ahead, the ECMO machine market is expected to grow as healthcare systems invest in advanced critical care technologies. Continuous research and development in life-support equipment will improve device performance and patient outcomes. Expanding healthcare infrastructure and increased training for healthcare professionals are also expected to support market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

  • Pumps
  • Oxygenator
  • Controllers
  • Cannula
  • Accessories

By Modality

  • Veno-Arterial
  • Veno-Venous
  • Arterio-Venous

By Application

  • Respiratory
  • Cardiac
  • ECPR

By Patient Type

  • Neonates
  • Pediatric
  • Adult

COMPANIES PROFILED

  • Medtronic Plc, Maquet Holding, Microport Scientific Corporation, Terumo Cardiovascular System Corporation, Medos Medizintechnik, Nipro Medical Corporation, LivaNova PLC, CytoSorbents Corporation, Eurosets SRL
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY COMPONENT 2022-2034 (USD MN and K Units)

  • 4.1. Market Analysis, Insights and Forecast Component
  • 4.2. Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.3. Oxygenator Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.4. Controllers Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.5. Cannula Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.6. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY MODALITY 2022-2034 (USD MN and K Units)

  • 5.1. Market Analysis, Insights and Forecast Modality
  • 5.2. Veno-Arterial Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.3. Veno-Venous Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.4. Arterio-Venous Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY APPLICATION 2022-2034 (USD MN and K Units)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Respiratory Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.3. Cardiac Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.4. ECPR Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY PATIENT TYPE 2022-2034 (USD MN and K Units)

  • 7.1. Market Analysis, Insights and Forecast Patient Type
  • 7.2. Neonates Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 7.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 7.4. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY REGION 2022-2034 (USD MN and K Units)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 8.2.1 By Component
    • 8.2.2 By Modality
    • 8.2.3 By Application
    • 8.2.4 By Patient Type
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 8.3.1 By Component
    • 8.3.2 By Modality
    • 8.3.3 By Application
    • 8.3.4 By Patient Type
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 8.4.1 By Component
    • 8.4.2 By Modality
    • 8.4.3 By Application
    • 8.4.4 By Patient Type
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 8.5.1 By Component
    • 8.5.2 By Modality
    • 8.5.3 By Application
    • 8.5.4 By Patient Type
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 8.6.1 By Component
    • 8.6.2 By Modality
    • 8.6.3 By Application
    • 8.6.4 By Patient Type
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Medtronic Plc
    • 10.2.2 Maquet Holding
    • 10.2.3 Microport Scientific Corporation
    • 10.2.4 Terumo Cardiovascular System Corporation
    • 10.2.5 Medos Medizintechnik
    • 10.2.6 Nipro Medical Corporation
    • 10.2.7 LivaNova PLC
    • 10.2.8 CytoSorbents Corporation
    • 10.2.9 Eurosets S.R.L